Document Detail


Lack of effect of food on the steady state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.
MedLine Citation:
PMID:  9330779     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of food on the pharmacokinetics of BMS-181101, a new anti-depressant under development, was investigated in 12 healthy male volunteers at steady state. Each subject received a 15 mg oral dose of BMS-181101 twice a day (q 12 h) for 11 days and a morning dose of BMS-181101 on day 12. Six subjects were randomly assigned to receive BMS-181101 under fasted conditions from days 1 to 6 and then crossed over to fed conditions from days 7 to 12. The other six subjects received the reverse conditions, fed for days 1-6 and fasted for days 7-12. Serial blood samples were collected up to 12 h on days 6 and 12 following the administration of the morning dose. In addition, trough blood samples were collected on days 4, 5, 10, and 11 prior to the morning dose. Plasma samples were analyzed for intact BMS-181101 using a validated high-performance liquid chromatography method with an electrochemical detector. BMS-181101 was well tolerated both with and without ingestion of food. The statistical evaluation of the Cmin values indicated that steady state of BMS-181101 was achieved by the fourth day of dosing regardless of whether the subject was fasted or fed. When BMS-181101 was administered with food, Cmax was reduced by about 25% and tmax was prolonged by 1 h. However, AUCtau, t1/2, and time to attain steady state of BMS-181101 were not altered by ingestion of food. In summary, BMS-181101 can be given with food without adversely impacting the safety or pharmacokinetic profiles of the drug.
Authors:
N R Srinivas; W C Shyu; J Lee; D S Greene; R H Barbhaiya
Related Documents :
759069 - Effect of food on kinetics of 8-methoxsalen.
8490109 - Influence of food on the disposition of the monoamine oxidase-a inhibitor brofaromine i...
1261769 - Intestinal propulsion in the dog. its relation to food intake and the migratory myoelec...
11694619 - Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by caco-2 human ...
3377469 - Influence of food on bioavailability of amdinocillin pivoxil.
19304259 - Comparison of fast-food and non-fast-food children's menu items.
12408629 - The impact of oestrogenic and androgenic contamination on marine organisms in the unite...
16805419 - Risk of allergy to food proteins in topical medicinal agents and cosmetics.
8757449 - Liquid chromatographic determination of tocopherols and tocotrienols in margarine, infa...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Biopharmaceutics & drug disposition     Volume:  18     ISSN:  0142-2782     ISO Abbreviation:  Biopharm Drug Dispos     Publication Date:  1997 Oct 
Date Detail:
Created Date:  1997-11-24     Completed Date:  1997-11-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7911226     Medline TA:  Biopharm Drug Dispos     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  585-93     Citation Subset:  IM    
Affiliation:
Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Analysis of Variance
Antidepressive Agents / administration & dosage,  pharmacokinetics*
Area Under Curve
Cross-Over Studies
Diet
Fasting
Food-Drug Interactions*
Humans
Male
Piperazines / administration & dosage,  pharmacokinetics*
Pyrimidines / administration & dosage,  pharmacokinetics*
Chemical
Reg. No./Substance:
0/Antidepressive Agents; 0/BMS 181101; 0/Piperazines; 0/Pyrimidines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Integrated pharmacokinetic and metabolic modeling of selegiline and metabolites after transdermal ad...
Next Document:  Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamic...